Biotech Valuations 101; NVLX Shares Are Cheap
With major milestones achieved in just a few months and several more ahead, plus trading at a big discount to its peers, what more could an investor ask for in a stock?
Read more...
 
LifeApps Perfectly Positioned to Ride Digital Publishing Trends

Whether consumers use a tablet or a smart phone, early-mover LifeApps is a clear beneficiary of the huge growth in the digital publish arena, especially since the sports and fitness segment is one of the major drivers of this growth.

Read more...
 
Nuvilex Has Cleared the Common Biotech Hurdles
With big check marks alongside these hurdles, Nuvilex has the potential to become one of biotech’s major players, given its roadmap in the treatment of cancer and diabetes. As a result, the Company’s stock is poised to enjoy a high valuation at a premium to other biotechs.
Read more...
 
Coca-Cola Study Results Suggest Potential Benefit to Plandaí Biotechnology
Plandaí’s aggressive marketing campaign will reap major benefits as the message that beverages and other products that utilize the Phytofare™ products can provide superior levels of healthy ingredients, such as the polyphenols mentioned above. This differentiation should help the Company expand its market share and generate strong results in 2014.
Read more...
 
Structural Changes Could Benefit Nuvilex Shareholders

It is not uncommon for entrepreneurial or young firms to engage in various strategies or iterations through the lifecycle of the Firm. In some cases, legacy business segments, while smaller or seemingly less important than other, newer initiatives, even if they are profitable, often take a back seat to the new focus of a given company as the new programs likely offer greater potential.

Read more...
 
The Next Major Software Company

Unisource Corp. is well-positioned to emerge as the next major cloud-based software player in the SaaS segment.

Read more...
 
BLUF: LOI & Thesis Clarification
Our investment thesis that BluForest could become a major player in the sale of verified carbon offsets through reforestation is largely based upon the Company’s balance sheet.
Read more...
 
Plandaí Shares Hit New Year High Despite Market Slump

Shares of Plandaí Biotechnology Inc. (OTCQB – PLPL - $0.66 – Spec Buy) closed at a new 52-week high yesterday, despite the current stock market slump. The shares may be further bolstered by results of a research study conducted by The Coca-Cola Company (NYSE – KO).

Read more...
 
New FDA Program Benefits Nuvilex

When events in progress take longer to complete than originally expected, investors often forget that upcoming events may be as important or even more critical than previous milestones. For longtime investors in Nuvilex, Inc. (OTCQB – NVLX - $0.15 - Spec Buy), so much attention was paid to technology, efficacy, and past clinical trial results that key changes within the Federal Drug Administration (FDA) seem to have gone unnoticed.

Read more...
 
LifeApps: Health and Wellness at a Touch of Finger

By providing sport and health enthusiasts with high-end guidance and content from experts on their mobile devices at a time of their choosing, users are able to maximize the recreation time in their daily lives through the Company’s apps.

Read more...
 
<< Start < Prev 31 32 33 34 35 36 37 38 39 40 Next > End >>

Page 32 of 47